Top Markets
Coin of the day
Circio Holding ASA Circio Holding ASA

Circio Holding ASA

CRNA
Rang in Aktien #18603
Circio Holding ASA, a biotechnology firm based in Oslo, Norway, and founded in... Circio Holding ASA, a biotechnology firm based in Oslo, Norway, and founded in 2010, specializes in the development of advanced circular RNA and immunotherapy treatments. Among its key innovations is TG01, a cancer vaccine aimed at specific driver mutations, which is currently progressing through three clinical trials for indications including multiple myeloma, pancreatic cancer, and lung cancer. The company also pioneers the circVec circRNA vector platform, an adaptable genetic module designed to facilitate the creation of diverse functional circular RNAs within human cells. This circVec platform is further supported by a collaborative agreement with Certest Biotec, S.L., focusing on its formulation. Formerly known as Targovax ASA, the company officially rebranded to Circio Holding ASA in May 2023.
Aktienkurs
$0.88044964
Zuletzt synchronisiert: 2026-07-31
Marktkapitalisierung
$192.54M
Veränderung (1 Tag)
-0.71%
Veränderung (1 Jahr)
1,362.12%
Land
NO
Handel Circio Holding ASA (CRNA)

Kategorie

Dividendenhistorie für Circio Holding ASA (CRNA)
Circio Holding ASA (Aktienkürzel: CRNA) zahlte insgesamt 0 Dividenden.
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: 0.00
Dividendenrendite (TTM): 0
Dividendenzahlungen für Circio Holding ASA (CRNA) von 2026 bis 2026
Jährliche Dividendenzahlungen
Jahr Dividende (angepasst an Aktiensplits) ändert
Nicht genügend Daten für die angegebenen Daten.
Liste aller Dividendenzahlungen
Jahr Dividende ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenzahlungen ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Dividendenzahlungen Land
0.00%
US
0.00%
NL
0.00%
US
64.00%
AU
0.00%
CH